Life expectancy of HIV-positive adults: a review.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Sexual Health

• Publication date

  2011-11-30

• Fields of study

  Medicine

• Identifiers
  DOI 10.1071/SH11046PMID 22127039
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Estimating the impact of antiretroviral therapy: regional and global estimates of life-years gained among adults

  2010cited by this paper
• Impact on life expectancy of late diagnosis and treatment of HIV-1 infected individuals: UK CHIC

  2010cited by this paper
• Life Expectancy After HIV Diagnosis Based on National HIV Surveillance Data From 25 States, United States

  2010cited by this paper
• Prevalence of comedications and effect of potential drug–drug interactions in the Swiss HIV Cohort Study

  2010cited by this paper
• Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996-2006: collaborative analysis of 13 HIV cohort studies.

  2010cited by this paper
• Highly active antiretroviral treatment as prevention of HIV transmission: review of scientific evidence and update

  2010cited by this paper
• Growing old with HIV — dealing with co-morbidities

  2010cited by this paper
• Trends over calendar time in antiretroviral treatment success and failure in HIV clinic populations *

  2010cited by this paper
• Life expectancy of recently diagnosed asymptomatic HIV-infected patients approaches that of uninfected individuals

  2010cited by this paper
• HIV therapy in an ageing population — the challenge of polypharmacy

  2010cited by this paper
• Prognosis of patients treated with cART from 36 months after initiation, according to current and previous CD4 cell count and plasma HIV-1 RNA measurements

  2009cited by this paper
• Racial and sex disparities in life expectancy losses among HIV-infected persons in the united states: impact of risk behavior, late initiation, and early discontinuation of antiretroviral therapy.

  2009cited by this paper
• Epidemiology of nonkeratinocytic skin cancers among persons with AIDS in the United States

  2009cited by this paper
• Mortality of HIV-infected patients starting potent antiretroviral therapy: comparison with the general population in nine industrialized countries.

  2009cited by this paper
• Commentary: Cornfield on cigarette smoking and lung cancer and how to assess causality.

  2009cited by this paper
• Life and death in the cART era.

  2008cited by this paper
• Stability of antiretroviral regimens in patients with viral suppression

  2008cited by this paper
• Patterns and predictors of the use of different antiretroviral drug regimens at treatment initiation in the UK

  2008cited by this paper
• Are previous treatment interruptions associated with higher viral rebound rates in patients with viral suppression?

  2008cited by this paper
• Increased regimen durability in the era of once-daily fixed-dose combination antiretroviral therapy

  2008cited by this paper
• Changes in the risk of death after HIV seroconversion compared with mortality in the general population.

  2008cited by this paper
• Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel.

  2008cited by this paper
• Estimating the lost benefits of antiretroviral drug use in South Africa.

  2008cited by this paper
• Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies.

  2008cited by this paper
• Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel.

  2008cited by this paper
• Gender and the Use of Antiretroviral Treatment in Resource-Constrained Settings: Findings from a Multicenter Collaboration

  2008cited by this paper
• Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy: a randomized trial.

  2008cited by this paper
• Survival of Persons with and without HIV Infection in Denmark, 19952005

  2007cited by this paper
• Evidence of a decline in transmitted HIV-1 drug resistance in the United Kingdom

  2007cited by this paper
• Improved survival in HIV-infected persons: consequences and perspectives.

  2007cited by this paper
• Prognosis of HIV-1-infected patients up to 5 years after initiation of HAART: collaborative analysis of prospective studies

  2007cited by this paper
• Success of clinical care for human immunodeficiency virus infection according to demographic group among sexually infected patients in a routine clinic population, 1999 to 2004.

  2007cited by this paper
• Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach. 2006 revision.

  2006cited by this paper
• The survival benefits of AIDS treatment in the United States.

  2006cited by this paper
• Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries.

  2006cited by this paper
• The late diagnosis and consequent short-term mortality of HIV-infected heterosexuals (England and Wales, 2000–2004)

  2006cited by this paper
• Population and Mortality after AIDS

  2006cited by this paper
• British HIV Association guidelines for the treatment of HIV‐1‐infected adults with antiretroviral therapy 2008

  2005cited by this paper
• Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study.

  2005cited by this paper
• Primary care delivery is associated with greater physician experience and improved survival among persons with AIDS

  2003cited by this paper
• Modelling the 3‐year risk of myocardial infarction among participants in the Data Collection on Adverse Events of Anti‐HIV Drugs (DAD) study

  2003cited by this paper
• Improved methods and assumptions for estimation of the HIV/AIDS epidemic and its impact: Recommendations of the UNAIDS Reference Group on Estimates, Modelling and Projections.

  2002cited by this paper
• Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies.

  2002cited by this paper
• Guidelines for Using Antiretroviral Agents among HIV-Infected Adults and Adolescents: The Panel on Clinical Practices for Treatment of HIV*

  2002cited by this paper
• A tale of two futures: HIV and antiretroviral therapy in San Francisco.

  2000cited by this paper
• Modern Antiretroviral Therapy Improves Life Expectancy of Gay and Bisexual Males in Vancouver’s West End

  2000cited by this paper
• Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis

  2000cited by this paper
• British HIV Association (BHIVA) guidelines for the treatment of HIV‐infected adults with antiretroviral therapy

  2000cited by this paper
• The British Diabetic Association Cohort Study, I: all‐cause mortality in patients with insulin‐treated diabetes mellitus

  1999cited by this paper
• Improved survival among HIV-infected individuals following initiation of antiretroviral therapy.

  1998cited by this paper
• Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group.

  1998cited by this paper
• Increased incidence of cancer among homosexual men, New York City and San Francisco, 1978-1990.

  1996cited by this paper
• Years of potential life lost (YPLL)--what does it measure?

  1991cited by this paper
• Years of potential life lost (YPLL)--what does it measure?

  1990cited by this paper

• Prolonged QT Interval in HIV-1 Infected Humanized Mice Treated Chronically with Dolutegravir/Tenofovir Disoproxil Fumarate/Emtricitabine

  2026cites this paper
• Cerebrospinal fluid markers of alzheimer’s pathology relate to aMCI among people with HIV

  2026cites this paper
• Diastolic Dysfunction with Vascular Deficits in HIV-1-Infected Female Humanized Mice Treated with Antiretroviral Drugs

  2025cites this paper
• Longitudinal transcriptomic analysis of SIV-infected rhesus macaques reveals peripheral immune dynamics throughout untreated SIV infection and long-term antiretroviral therapy

  2025cites this paper
• Adenosine and Adenosine Deaminase Contrary Manifestations in Immunity

  2025cites this paper
• Early-career research education mentoring: a successful program in NeuroHIV and mental health (TRNAMH)

  2023cites this paper
• Co-designing health services for people living with HIV who have multimorbidity: a feasibility study.

  2023cites this paper
• Efficacy and safety of 400 mg efavirenz versus standard 600 mg dose when taken with tenofovir and lamivudine combination in Indian adult patients with HIV-1 infection: An open-label, interventional, randomized, non-inferiority trial

  2022cites this paper
• Peer-Led Community-Based Support Services and HIV Treatment Outcomes Among People Living With HIV in Wuxi, China: Propensity Score–Matched Analysis of Surveillance Data From 2006 to 2021

  2022cites this paper
• CSF markers of AD-related pathology relate specifically to memory impairment in older people with HIV: a pilot study

  2022cites this paper
• To what extent were life expectancy gains in South Africa attributable to declines in HIV/AIDS mortality from 2006 to 2017? A life table analysis of age-specific mortality

  2022cites this paper
• Mortality and Causes of Death among Individuals Diagnosed with Human Immunodeficiency Virus in Korea, 2004–2018: An Analysis of a Nationwide Population-Based Claims Database

  2022cites this paper
• Exploring the global animal biodiversity in the search for new drugs -Amphibians

  2021cites this paper
• Impact of HIV on Cognitive Performance in Professional Drivers

  2021cites this paper
• Drug discovery and development: An overview of modern methods and principles

  2021cites this paper
• Pandemics in Human History: A Study of Origin, Enormity, Mortality Rate and Controlling Strategies

  2020cites this paper
• Andronov–Hopf and Neimark–Sacker bifurcations in time-delay differential equations and difference equations with applications to models for diseases and animal populations

  2020cites this paper
• Ambulatory blood pressure monitoring in PLHIV in Malawi: preliminary findings.

  2020cites this paper
• Effectiveness and Safety of Antiretroviral Treatment in Pre- and Postmenopausal Women Living with HIV in a Multicentre Cohort

  2020cites this paper
• Evaluating the Effects of an Interdisciplinary Practice Model with Evaluating the Effects of an Interdisciplinary Practice Model with Pharmacist Collaboration on HIV Patient Co-Morbidities Pharmacist Collaboration on HIV Patient Co-Morbidities

  2020cites this paper
• The Impact of HIV-Associated Neurocognitive Impairment on Driving Performance in Commercial Truck Drivers

  2020cites this paper
• Prevalence and clinical outcomes of poor immune response despite virologically suppressive antiretroviral therapy among children and adolescents with HIV in Europe and Thailand: cohort study.

  2019cites this paper
• Cognitive impairment among older adults living with HIV/AIDS and frailty.

  2019cites this paper
• Current Challenges and Solutions in Research and Clinical Care of Older Persons Living with HIV: Findings Presented at the 9th International Workshop on HIV and Aging

  2019cites this paper
• Determinants of AIDS and non-AIDS related mortality among people living with HIV in Shiraz, southern Iran: a 20-year retrospective follow-up study

  2019cites this paper
• 24-h-Blutdruckmessung bei HIV+-Patienten in Malawi: Ergebnisse einer Pilotstudie

  2019influential citation
• The current understanding of overlap between characteristics of HIV-associated neurocognitive disorders and Alzheimer’s disease

  2019cites this paper
• Stigma and Dissatisfaction of Health Care Personnel in HIV Response in Iran: A Qualitative Study

  2019cites this paper
• Indolylarylsulfones, a fascinating story of highly potent human immunodeficiency virus type 1 non-nucleoside reverse transcriptase inhibitors

  2018cites this paper
• Empirical estimation of life expectancy from a linked health database of adults who entered care for HIV

  2018cites this paper
• Disparities and Determinants of Cancer Treatment in Elderly Americans Living With Human Immunodeficiency Virus/AIDS

  2018cites this paper
• Study on Dual Inhibitors of HIV-1 IN/CCR5 Caffeoyl Derivatives as Neuroprotective Agents

  2018cites this paper
• Cognitive Performance and Frailty in Older HIV-Positive Adults

  2018cites this paper
• Mathematical analysis of a model for Human Immunodeficiency Virus (HIV) endemicity

  2018cites this paper
• Quality of life of people living with HIV/AIDS in Finland

  2018cites this paper
• HIV and kidney: a dangerous liaison.

  2017cites this paper
• Cooccurrences of Putative Endogenous Retrovirus-Associated Diseases

  2017cites this paper
• Lymphocyte CD4+ cell count, strength improvements, heart rate and body composition of HIV-positive patients during a 3-month strength training program.

  2017cites this paper
• Life expectancy of HIV‐positive people after starting combination antiretroviral therapy: a meta‐analysis

  2017cites this paper
• The effects of setarud on the immunological status of HIV-positive patients: Efficacy of a novel multi-herbal drug

  2017cites this paper
• Chiral Indolylarylsulfone Non-Nucleoside Reverse Transcriptase Inhibitors as New Potent and Broad Spectrum Anti-HIV-1 Agents.

  2017cites this paper
• Causes of death and mortality trends of all individuals reported with HIV/AIDS in Israel, 1985–2010

  2017cites this paper
• Risk factors in the HIV population Traditional CKD

  2017cites this paper
• HIV-associated cystic lesions of the parotid gland.

  2017cites this paper
• A descriptive study on the knowledge of early diagnosis and treatment of HIV/AIDS and experiences of suspected exposure among nursing students in a selected nursing college, Ajitgarh, 2014

  2017cites this paper
• Coming of age in Khayelitsha: gendered identity, sexual partnerships and the transition to adulthood

  2017cites this paper
• Transplantation of the Patient with Human Immunodeficiency Virus.

  2017cites this paper
• risk factors for premature nuclear cataract formation in human immunodeficiency virus hiv infected individuals receiving antiretroviral therapy

  2016cites this paper
• Clinical Microbiology: Open Access

  2016cites this paper
• All-oral Direct-acting Antiviral Regimens in HIV/Hepatitis C Virus-coinfected Patients With Cirrhosis Are Efficient and Safe: Real-life Results From the Prospective ANRS CO13-HEPAVIH Cohort.

  2016cites this paper
• Envelhecimento e HIV/AIDS: devemos individualizar a terapia inicial?

  2016cites this paper
• Functional and clinical consequences of immune-driven sequence variation of gag-protease in HIV-1 subtypes A, C, D and recombinants.

  2016cites this paper
• Evaluating the Effects of an Interdisciplinary Practice Model with Pharmacist Collaboration on HIV Patient Co-Morbidities

  2016cites this paper
• Anti-HIV-1 activity of compounds derived from marine alga Canistrocarpus cervicornis

  2016cites this paper
• Overall and cause-specific excess mortality in HIV-positive persons compared with the general population

  2016cites this paper
• Prevalence of Hiv/Aids and Pulmonary Tuberculosis Co-Infection among Patients Attending Some Health Centres of Bauchi Metropolis

  2016cites this paper
• [Mortality in people infected by Human Immunodeficiency Virus].

  2016cites this paper
• Situation d'emploi des personnes vivant avec Le VIH en France au cours des années 2000 : rôles de l'évolution de la prise en charge et du contexte socioéconomique général

  2016cites this paper
• Comparison of risk and age at diagnosis of myocardial infarction, end-stage renal disease, and non-AIDS-defining cancer in HIV-infected versus uninfected adults.

  2015cites this paper
• Caenorhabditis elegans as a Model System for Studying Drug Induced Mitochondrial Toxicity

  2015cites this paper
• The Acute Care Physical Therapy HIV/AIDS Patient Population

  2015cites this paper
• Evaluating the Effects of an Interdisciplinary Practice Model with Pharmacist Collaboration on HIV Patient Co-Morbidities

  2015cites this paper
• Validity and Reliability of Total Lymphocyte Count as Alternative Biomarker for CD4 Count in the Management of HIV Positive Patients on HAART in Osogbo, Nigeria

  2015cites this paper
• Challenges and Clinical Decision‐Making in HIV‐to‐HIV Transplantation: Insights From the HIV Literature

  2015cites this paper
• Antiretroviral treatment failure predicts mortality in rural Tanzania

  2015cites this paper
• AIDS-A Clear and Present Danger

  2015cites this paper
• Mortality, Causes of Death and Associated Factors Relate to a Large HIV Population-Based Cohort

  2015cites this paper
• Sexual inactivity among men who have sex with men living with hiv in europe

  2015cites this paper
• Epidemiological profile of Tuberculosis in Sinazongwe District in the context of HIV/AIDS

  2015cites this paper
• Chapter 1 – Drug Discovery and Development: An Overview of Modern Methods and Principles

  2015cites this paper
• Comparison of renal changes with lopinavir/ritonavir plus raltegravir or tenofovir/emtricitabine in the PROGRESS study

  2014cites this paper
• Knowledge and Practices of Barbers Regarding HIV Transmission in Karachi: A Cross-Sectional Study

  2014cites this paper
• Impact of Risk Factors for Specific Causes of Death in the First and Subsequent Years of Antiretroviral Therapy Among HIV-Infected Patients

  2014cites this paper
• Life Expectancy in the Immune Recovery Era: The Evolving Scenario of the HIV Epidemic in Northern Italy

  2014cites this paper
• Detrimental impact of remote methamphetamine dependence on neurocognitive and everyday functioning in older but not younger HIV+ adults: evidence for a legacy effect?

  2014cites this paper
• Detection of HLA-B*57:01 by real-time PCR: implementation into routine clinical practice and additional validation data.

  2014cites this paper
• Antiretroviral agents increase NO production in gp120/IFNγ-stimulated cultures of rat microglia via an arginase-dependent mechanism.

  2014cites this paper
• Developing regulatory strategy for microbicides.

  2014cites this paper
• Where Does Treatment Optimism Fit in? Examining Factors Associated with Consistent Condom Use Among People Receiving Antiretroviral Treatment in Rio de Janeiro, Brazil

  2014cites this paper
• Log‐mean linear regression models for binary responses with an application to multimorbidity

  2014cites this paper
• Causes of death among HIV-infected patients in France in 2010 (national survey): trends since 2000

  2014cites this paper
• Causes of death in HIV-infected patients from the Cologne–Bonn cohort

  2014cites this paper
• Effect of HIV Infection and Antiretroviral Therapy Duration on Reticulocyte Count and Red Cell Indices

  2014cites this paper
• Sequential pregnancies among women living with HIV in the United Kingdom and Ireland

  2014cites this paper
• Explaining the hindering factors for accepting the disease, a barrier for the HIV/AIDS patients to seek treatment: A qualitative study

  2014influential citation
• Comparison Between Flow Cytometry and Bead Method in Counting Cd4 and Cd8 T Lymphocytes in Mouse Spleen Cells Suspension

  2014cites this paper
• Reproductive Right of HIV Infected Person and Assisted Reproduction

  2014cites this paper
• Mind the gap: difference between Framingham heart age and real age increases with age in HIV-positive individuals–a clinical cohort study

  2013cites this paper
• Human immunodeficiency virus and menopause

  2013cites this paper
• Unsafe law: health, rights and the legal response to HIV

  2013cites this paper
• Do people with HIV infection have a normal life expectancy in the era of combination antiretroviral therapy?

  2013cites this paper
• The role of drug disposition genes for variability in the pharmacokinetics of antiretroviral drugs

  2013cites this paper
• and Prevention Services

  2013cites this paper
• Access to Treatment, Care, Support, and Prevention Services

  2013cites this paper
• Quinoline-based HIV integrase inhibitors.

  2013cites this paper
• Combinatorial anti-HIV gene therapy: using a multipronged approach to reach beyond HAART

  2013cites this paper
• Premature and accelerated aging: HIV or HAART?

  2013cites this paper
• Causes of death in HIV-infected patients from the Cologne-Bonn cohort K. EhrenC. HertensteinT. KummerleJ. J. VehreschildJ. FischerD. Gillor • C. WyenC. LehmannO. A. CornelyN. JungS. GravemannM. Platten •

  2013cites this paper
• Aging with HIV: a practical review

  2013cites this paper
• Oral conditions and their social impact among HIV dental patients, 18 years on.

  2013cites this paper